WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis

NCT02182544 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

151

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Perennial

Interventions

DRUG: WAL801CL dry syrup
DRUG: Ketotifen fumarate dry syrup
DRUG: Ketotifen fumarate dry syrup placebo
DRUG: WAL 801 CL dry syrup placebo

Sponsor

Boehringer Ingelheim